Biology and fat cells

Why choose Adipeau over Volufiline?

By April 9th, 2026No Comments6 min read

Both products share the same
goal: fuller looking skin

Adipeau: Fuller looking skin

Volufiline: Fuller looking skin

Adipeau and Volufiline are both plant-based topicals designed to help skin appear fuller. They share the same intended cosmetic result.
The question is not what they promise — it’s how well each one can support that promise with evidence.

Both use plant-derived active ingredients

Adipeau: KPE / PMFs

Volufiline: Sarsasapogenin

Adipeau’s formulas are powered by polymethoxyflavonoids (PMFs) from Kaempferia Parviflora Extract.

Volufiline’s active ingredient is sarsasapogenin, a plant-derived saponin.

Both are naturally sourced. The difference lies in what has been studied, published, and independently validated about each ingredient and the finished products that contain them.

KPRE mechanism of action supported by peer-reviewed research

Adipeau: Yes

Volufiline: No

Multiple peer-reviewed publications document the effects of Kaempferia Parviflora Extract on adipocyte biology. These studies describe PMFs’ role in adipocyte differentiation and reduction of adipocyte size in controlled laboratory conditions.

There are no published peer-reviewed papers documenting the mechanism of action of sarsasapogenin on adipocytes. The only available data comes from a white paper produced by Sederma, Volufiline’s manufacturer, which has not undergone independent peer review.

Key references: Okabe et al., Phytomedicine 2014 (PMID: 24629599); Horikawa T et al., Biol Pharm Bull 2012 (PMID: 22687402).

Sources: PMID: 24629599 · PMID: 22687402

KPRE validated in human adipocyte models

Adipeau: Yes

Volufiline: No

Dr. Volker Lauschke’s laboratory at the Karolinska Institute has independently validated the mechanism of action of Kaempferia Parviflora Extract in in vitro studies. Results have been submitted for publication.

Volufiline’s mechanism of action has not been independently validated outside of the manufacturer’s own white paper.

KPRE has peer-reviewed penetration data

Adipeau: Yes

Volufiline: No

For any topical skincare ingredient, penetration is a critical question: can the active actually reach its target in the skin?

Peer-reviewed studies have examined and documented the skin penetration properties of Kaempferia Parviflora Extract.

No peer-reviewed penetration studies exist for sarsasapogenin. The Sederma white paper does not address this question.

Adipeau has skin explant studies with the finished formulation

Adipeau: Yes

Volufiline: No

Adipeau has conducted skin explant studies — tests on living human skin tissue — using its actual finished formulation, not just the isolated ingredient.

These studies bridge the gap between laboratory ingredient research and real-world product performance.

Volufiline has no published skin explant studies with its finished formulation.

Adipeau has clinical studies with the finished formulation

Adipeau: Yes

Volufiline: No

Adipeau has conducted clinical studies using the actual products consumers purchase, with pre-specified endpoints and objective measurement tools including 3D imaging technology.

These studies track the same finished formulations sold to consumers.

Volufiline has no published clinical studies conducted with its finished consumer formulation.

Adipeau has a registered study on facial skin with pre-specified endpoints

Adipeau: Yes

Volufiline: No

Adipeau’s 3D imaging study is registered on ClinicalTrials.gov and tracks facial skin outcomes over more than two years with pre-specified endpoints. This is the standard expected of credible clinical research.

Volufiline has no registered studies examining facial skin outcomes.

ClinicalTrials.gov Identifier: NCT04769193

Source: clinicaltrials.gov/study/NCT04769193

Adipeau has a registered study on body skin with a pre-specified endpoint

Adipeau: Yes

Sederma: No

Adipeau registered a cellulite treatment study with the UK Clinical Trials Repository (ISRCTN Identifier: ISRCTN14923731) evaluating cellulite severity after 3 months of treatment with the strength gel.

Sederma conducted an unregistered breast skin study which failed to achieve a statistically significant result.

Adipeau has a confirmatory body skin study

Adipeau: Yes

Volufiline: No

Adipeau has conducted a second, confirmatory study on body skin to strengthen the reliability of its findings.

Replication is a cornerstone of credible evidence — a single study, no matter how well designed, is strengthened when its findings are confirmed independently.

Volufiline has not conducted a confirmatory study.

Adipeau's real world results are consistent with clinical data

Adipeau: Yes

Volufiline: No

Adipeau’s website features a continuous flow of user-generated before-and-after photos. These real-world results are consistent with the outcomes observed in Adipeau’s clinical studies: gradual, natural-looking improvements in the appearance of skin fullness over weeks and months.

Volufiline’s user-generated results, documented on platforms like Reddit, show a different pattern — including rapid changes in appearance within days.

Sources: adipeau.com/clinical-evidence  ·  Reddit r/30PlusSkinCare

No demonstrated potential for unwanted fullness gains with Adipeau

Adipeau: Yes

Volufiline: No

Volufiline users have reported unwanted increases in fullness appearance in areas where they were not desired. These reports are documented in user-generated content on public forums.

Across Adipeau’s clinical studies and extensive real-world case studies, there are no reported instances of unwanted or out-of-place fullness gains. The appearance improvements observed in Adipeau users have been consistent and predictable.

Full Comparison: Adipeau vs. Volufiline

Evidence Category Adipeau Volufiline
Intended result Fuller looking skin Fuller looking skin
Key ingredient PMFs from KPE Sarsasapogenin
Peer-reviewed MOA for key ingredient Yes No
Independent lab studies of ingredient MOA Yes No
Peer-reviewed penetration studies Yes No
Independent skin explant studies with formulation Yes No
Clinical studies with finished formulation Yes No
Registered facial skin study Yes No
Registered body skin study Yes No
Confirmatory body skin study Yes No
Real-world results consistent with clinical data Yes No
No potential for unwanted fullness gains Yes No

Conclusion

Adipeau and Volufiline share the same cosmetic goal: helping skin look fuller. The difference is in the evidence.

Adipeau’s key ingredient has peer-reviewed research, independent laboratory validation, penetration studies, skin explant testing, and clinical studies with the finished formulation — including a registered facial skin study tracked over more than two years.

Volufiline’s evidence is limited to a manufacturer’s white paper and a single registered body skin study that did not achieve statistically significant results.

When choosing a product for your skin, the depth and quality of evidence matters.

Share
Ready to Try